Stock-based compensation - Stock option activity (Details) - Stock Options - USD ($) $ / shares in Units, $ in Millions |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jul. 31, 2022 |
Jan. 31, 2022 |
|
| Shares | ||
| Outstanding at beginning of period (in shares) | 2,825,752 | |
| Outstanding at end period (in shares) | 2,825,752 | 2,825,752 |
| Vested and exercisable (in shares) | 549,500 | |
| Weighted Average Exercise Price | ||
| Weighted Average Exercise Price Outstanding at beginning period (in dollars per share) | $ 10.76 | |
| Weighted Average Exercise Price Outstanding at end period (in dollars per share) | 10.76 | $ 10.76 |
| Weighted Average Exercise Price Vested and Exercisable (in dollars per share) | $ 10.75 | |
| Weighted Average Remaining Contractual Term (Years) | ||
| Weighted Average Remaining Contractual Term Outstanding (in Years) | 8 years 10 months 24 days | 9 years 4 months 24 days |
| Unrecognized equity-based compensation costs | $ 7.0 | |
| Cost expected to be recognized over a weighted-average period | 2 years 10 months 24 days |
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|